Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban vs Enoxaparin for Thromboprophylaxis After Knee Replacement
NCT00371683Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Nov 2006
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of apixaban in deep vein thrombosis (DVT), pulmonary embolism (PE), sponsored by Bristol Myers Squibb. Started Nov 2006; status: completed.
02
Drugs
apixaban
03
Conditions
deep vein thrombosis (DVT)pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT00371683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00371683.